These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 236615)

  • 41. [Treatment of neurogenic bladder using phenoxybenzamine and bethanechol in acute spinal cord lesions].
    Martínez Agulló E; Gallego Gómez J; Jiménez Cruz F; Gracia Pérez A
    Actas Urol Esp; 1983; 7(1):23-8. PubMed ID: 6136159
    [No Abstract]   [Full Text] [Related]  

  • 42. Pharmacological studies of the uninhibited neurogenic bladder. III. The influence of adrenergic excitatory and inhibitory drugs on the cystometrogram of neurological patients with normal and uninhibited neurogenic bladder.
    Jensen D
    Acta Neurol Scand; 1981 Dec; 64(6):401-26. PubMed ID: 6127859
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The place of alpha-blocking drugs in the treatment of children with neuropathic bladders.
    Harrison NW; Whitfield HN; Williams DI
    Urol Int; 1977; 32(2-3):224-31. PubMed ID: 906185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of the adrenergic nervous system on the lower urinary tract and its clinical implications.
    Norlén L; Sundin T
    Int Rehabil Med; 1982; 4(1):37-43. PubMed ID: 6178707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical effect of new alpha-adrenergic blocker on micturition disturbance of neurogenic bladder and lower urinary tract obstruction].
    Takimoto Y; Kitamura K; Fuse T; Kawazoe K; Hirano D; Amagai T; Kiyotaki S
    Hinyokika Kiyo; 1983 Feb; 29(2):255-63. PubMed ID: 6145342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The pharmacological treatment of the incontinent neurogenic bladder (author's transl)].
    Herrlinger A; Schrott KM
    Urologe A; 1978 Sep; 17(5):349-52. PubMed ID: 706018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urethral pressure profile and hemodynamic effects of phenoxybenzamine and prazosin in non-sedated male beagle dogs.
    Fischer JR; Lane IF; Cribb AE
    Can J Vet Res; 2003 Jan; 67(1):30-8. PubMed ID: 12528826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urodynamic findings and long-term outcome management of patients with multiple sclerosis-induced lower urinary tract dysfunction.
    McGuire EJ; Savastano JA
    J Urol; 1984 Oct; 132(4):713-5. PubMed ID: 6147423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The sympathetic innervation and adrenoreceptor function of the human lower urinary tract in the normal state and after parasympathetic denervation.
    Sundin T; Dahlström A; Norlén L; Svedmyr N
    Invest Urol; 1977 Jan; 14(4):322-8. PubMed ID: 836469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacologic treatment of lower urinary tract dysfunction in geriatric patients.
    Goode PS; Burgio KL
    Am J Med Sci; 1997 Oct; 314(4):262-7. PubMed ID: 9332266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urethral response during bladder contraction induced by subcutaneous bethanechol chloride: elicitation of a sympathetic reflex urethral constriction.
    Sogbein SK; Downie JW; Awad SA
    J Urol; 1984 Apr; 131(4):791-5. PubMed ID: 6142968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies of enuresis. VI. Observations on sphincter-augmenting effect of imipramine in children with urinary incontinence.
    Mahony DT; Laferte RO; Mahoney JE
    Urology; 1973 Apr; 1(4):317-23. PubMed ID: 4588627
    [No Abstract]   [Full Text] [Related]  

  • 53. The stop-flow technique: a way to measure detrusor strength.
    Susset JG; Brissot RB; Regnier CH
    J Urol; 1982 Mar; 127(3):489-94. PubMed ID: 7062424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bladder transection--a functional, neurophysiological, neuropharmacological and neuroanatomical study.
    Staskin DR; Parsons KF; Levin RM; Wein AJ
    Br J Urol; 1981 Dec; 53(6):552-7. PubMed ID: 7317741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Urodynamic study of lower urinary tract. V. Alpha adrenergic blocker for the treatment of neurogenic bladder dysfunction (author's transl)].
    Kondo A; Otani T; Kobayashi M; Narita H; Takita T
    Nihon Hinyokika Gakkai Zasshi; 1978 Aug; 69(8):988-99. PubMed ID: 713212
    [No Abstract]   [Full Text] [Related]  

  • 56. Dysfunction of the detrusor and urethra in multiple sclerosis: the role of drug therapy.
    Awad SA; Wilson JW; Fenemore J; Kiruluta HG
    Can J Surg; 1982 May; 25(3):259-62. PubMed ID: 6123379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SYMPTOMATIC ENURESIS.
    CAMPBELL EW; SHAW JL
    Biochem Clin; 1963; 2():165-70. PubMed ID: 14095793
    [No Abstract]   [Full Text] [Related]  

  • 58. Drug therapy for lower urinary tract dysfunction.
    Finkbeiner AE; Bissada NK
    Urol Clin North Am; 1980 Feb; 7(1):3-16. PubMed ID: 7376303
    [No Abstract]   [Full Text] [Related]  

  • 59. Subclinical neurogenic bladder in children.
    Dorfman LE; Bailey J; Smith JP
    J Urol; 1969 Jan; 101(1):48-54. PubMed ID: 4882624
    [No Abstract]   [Full Text] [Related]  

  • 60. [Efficacy of combination of Ea-0643 (bunazosin hydrochloride) and bethanechol chloride in patients with neurogenic bladder].
    Araki T; Nakano S; Sugimura Y; Tochigi H; Kawamura J; Kato T; Tajima K; Chigusa I; Saito K; Morisita H
    Hinyokika Kiyo; 1990 Nov; 36(11):1379-83. PubMed ID: 1981126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.